These data suggest that Tp53 plays a central role in mediating the reduction in liver enlargement conferred by heterozygous ahctf1 expression in adult dox-treated TO(krasG12V)T/+ livers, in agreement with our findings with the larval model of HCC. This evidence concerns the gene TP53 and hepatocellular carcinoma.